Growth Metrics

bioAffinity Technologies (BIAF) Other Non-Current Assets (2021 - 2026)

bioAffinity Technologies has reported Other Non-Current Assets over the past 6 years, most recently at $12816.0 for Q1 2026.

  • Quarterly Other Non-Current Assets fell 34.86% to $12816.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $12816.0 through Mar 2026, down 34.86% year-over-year, with the annual reading at $12815.0 for FY2025, 34.87% down from the prior year.
  • Other Non-Current Assets was $12816.0 for Q1 2026 at bioAffinity Technologies, roughly flat from $12815.0 in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $19676.0 in Q3 2024 and troughed at $6000.0 in Q3 2022.
  • The 5-year median for Other Non-Current Assets is $12816.0 (2026), against an average of $13598.8.
  • Year-over-year, Other Non-Current Assets surged 184.32% in 2024 and then plummeted 34.87% in 2025.
  • A 5-year view of Other Non-Current Assets shows it stood at $6000.0 in 2022, then soared by 167.67% to $16060.0 in 2023, then rose by 22.52% to $19676.0 in 2024, then plummeted by 34.87% to $12815.0 in 2025, then rose by 0.01% to $12816.0 in 2026.
  • Per Business Quant, the three most recent readings for BIAF's Other Non-Current Assets are $12816.0 (Q1 2026), $12815.0 (Q4 2025), and $12815.0 (Q3 2025).